On 2025-05-29, Immunovant, Inc. (IMVT) announced earnings per share of $-0.64 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.72.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.76 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-29 | 2025-03-31 | $-0.72 | $-0.64 |
| 2025-02-06 | 2024-12-31 | $-0.73 | $-0.76 |
| 2024-11-07 | 2024-09-30 | $-0.61 | $-0.74 |
| 2024-08-06 | 2024-06-30 | $-0.52 | $-0.60 |
| 2024-05-29 | 2024-03-31 | $-0.43 | $-0.52 |
| 2024-02-12 | 2023-12-31 | $-0.44 | $-0.36 |
| 2023-11-09 | 2023-09-30 | $-0.46 | $-0.45 |
| 2023-08-10 | 2023-06-30 | $-0.44 | $-0.47 |
| 2023-05-22 | 2023-03-31 | $-0.48 | $-0.46 |
| 2023-02-03 | 2022-12-31 | $-0.41 | $-0.49 |
| 2022-11-04 | 2022-09-30 | $-0.41 | $-0.41 |
| 2022-08-05 | 2022-06-30 | $-0.40 | $-0.35 |
| 2022-06-08 | 2022-03-31 | $-0.38 | $-0.41 |
| 2022-02-04 | 2021-12-31 | $-0.34 | $-0.36 |
| 2021-11-05 | 2021-09-30 | $-0.26 | $-0.35 |
| 2021-08-09 | 2021-06-30 | $-0.30 | $-0.31 |
| 2021-06-01 | 2021-03-31 | $-0.33 | $-0.29 |
| 2021-02-16 | 2020-12-31 | $-0.26 | $-0.32 |
| 2020-11-12 | 2020-09-30 | $-0.33 | $-0.25 |
| 2020-08-12 | 2020-06-30 | $-0.35 | $-0.38 |
| 2020-06-29 | 2020-03-31 | $-0.53 | $-0.38 |
| 2020-02-14 | 2019-12-31 | $-0.25 | $-0.28 |